ФарФаР - Фармацеутски факултет, репозиторијум
Универзитет у Београду, Фармацеутски факултет
    • English
    • Српски
    • Српски (Serbia)
  • Српски (ћирилица) 
    • Енглески
    • Српски (ћирилица)
    • Српски (латиница)
  • Пријава
Преглед записа 
  •   ФарФаР
  • Pharmacy
  • Doktorati
  • Преглед записа
  •   ФарФаР
  • Pharmacy
  • Doktorati
  • Преглед записа
JavaScript is disabled for your browser. Some features of this site may not work without it.

Heminformatička analiza, dizajn i ispitivanje proapoptotske aktivnosti novih liganada imidazolinskih receptora

Cheminformatic analysis, design and examination of the proapoptotic activity of novel imidazoline receptor ligands

Thumbnail
2020
Disertacija.pdf (2.902Mb)
IzvestajKomisije23368.pdf (619.4Kb)
Аутори
Vučićević, Jelica
Остала ауторства
Nikolić, Katarina
Veljković, Nevena
Agbaba, Danica
Srdić-Rajić,Tatjana
Докторска теза (Објављена верзија)
Метаподаци
Приказ свих података о документу
Апстракт
Ligandi imidazolinskih receptora predstavljaju veliku grupu biološki aktivnih jedinjenja koja svoju aktivnost ostvaruju delovanjem na imidazolinske receptore (I1-IR, I2-IR, and I3-IR) i na α2-adrenergičke receptore (α2-AR). Centralni antihipertenzivni efekat imidazolina kao što su klonidin, rilmenidin i moksonidin je rezultat aktivacije I1-IR and α2-AR. I2-imidazolinski receptori predstavljaju katalitičko mesto monoamino oksidaze B (MAO-B), enzima koji je uključen u nekolio neuroloških poremećaja. Jedinjenja kao što su idazoksan i njegovi analozi pokazuju visok afinitet za ovaj tip receptora. I3-IRs imaju ulogu u indukciju sekrecije insulina iz β-ćelija pankreasa i održavanje homeostaze glukoze. Imajući u vidu da većina liganada imidazolinskih receptora svoje efekate ostvaruje unutar centralnog nervnog sistema (CNS) delujući kao centralni antihipertenzivi i/ili su potencijalni lekovi u lečenju neuroloških oboljenja, procena njihove permeabilnosti kroz krvno-moždanu barijeru (KMB) je od... suštinskog značaja u ranom otkriću lekova.U ovoj disertaciji KMB permeabilnost 18 liganda α2-adrenergičkih i/ili imidazolinskih receptora i 22 leka koja deluju na CNS je ispitana primenom paralelnog testa permeabilnosti na veštačkim membrana (eng. Parallel Artificial Membrane Permeability Assay, PAMPA) i bioparticione micelarne hromatografije (eng. Biopartitioning Micellar Chromatography, BMC). Vrednosti dobijene PAMPA (logPe) i BMC (logkBMC) su dalje analizirane kvantitativnim odnosom strukture i permeabilnosti jedinjenja (eng. Quantitative Structure-Permeability Relationship, QSPR).Dominantni molekulski/kajonski oblici na pH = 7,4 su određeni korišćenjem MarvinSketch 6.1.0 softvera. Geometrija odabranih molekulskih/katjonskih oblika ispitivanih jedinjenja je optimizovana primenom B3LYP /6-31G (d,p) nivoa Density Functional Theory (DTF) u ChemBio3D Ultra 13.0 programu. Deskriptori optimizovanih struktura su izračunati u ChemBio3D Ultra 13.0, Dragon 6.0 i ADMET Predictor 6.5 programima. logPe i logkBMC vrednosti su korišćene kao zavisne varijable (Y), dok suizračunati molekulski parametri predstavljali nezavisne varijable (X) u QSPR studiji.

Imidazoline receptor ligands are a numerous family of biologically active compounds known to produce central hypotensive effect by interaction with both α2-adrenoreceptors (α2-AR) and imidazoline receptors (I1-IR, I2-IR, and I3-IR). The central hypotensive effect of imidazoline derivatives such as clonidine, rilmenidine and moxonidine is results of activation both I1-IR and α2-AR. I2-IRs have been shown to be modulatory site for monoamine oxidase-B, enzyme responsible for several neurological disorders. This type of imidazoline ligand receptors have high affinity for idazoxan and its analogues. I3-IRs are involved in induction of insulin secretion from β-cells and maintaining glucose homeostasis. Since the most IRs ligands are examined as centrally acting antihypertensives and/or drug candidates for treatment of various neurological diseases, predicting their brain penetration is a critical step in early drug discovery phase.In the framework of this doctoral dissertation, the effective... Blood–Brain Barrier (BBB) permeability of 18 IRs/ α2-AR ligands and 22 Central Nervous System (CNS) drugs was experimentally determined by using both Parallel Artificial Membrane Permeability Assay (PAMPA) and Biopartitioning Micellar Chromatography (BMC) and further studied by the Quantitative-Structure-Permeability Relationship (QSPR) methodology.The dominant molecules/cations species of compounds have been calculated at pH = 7.4 by using MarvinSketch 6.1.0 software. The analyzed ligands were optimized using Density Functional Theory (B3LYP/6-31G(d,p)) included in ChemBio3D Ultra 13.0 program and molecule descriptors for optimized compounds were calculated using ChemBio3D Ultra 13.0, Dragon 6.0 and ADMET predictor 6.5 software. PAMPA effective permeabilities of examined compounds (logPe) and their logkBMC values were used as dependent variable (Y), while calculated molecular parametres were used as independent variables (X) in the QSPR study. SIMCA P+ 12.0 was used for Partial Least Square (PLS) analysis, while the stepwise Multiple Linear Regression (MLR) and Artificial Neural Networks (ANN) modeling were performed using STASTICA Neural Networks 4.0. Predictive potential of the formed models was confirmed by Leave-One-Out Cross- and external-validation and the most reliable models were selected.The descriptors that are important for model building are identified as well as their influence on BBB permeability...

Извор:
Универзитет у Београду, 2020
Издавач:
  • Универзитет у Београду, Фармацеутски факултет
[ Google Scholar ]
Handle
https://hdl.handle.net/21.15107/rcub_nardus_17590
URI
http://eteze.bg.ac.rs/application/showtheses?thesesId=7680
https://fedorabg.bg.ac.rs/fedora/get/o:22869/bdef:Content/download
http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=2048438370
https://nardus.mpn.gov.rs/handle/123456789/17590
https://farfar.pharmacy.bg.ac.rs/handle/123456789/3723
Колекције
  • Doktorati
Институција/група
Pharmacy
TY  - THES
AU  - Vučićević, Jelica
PY  - 2020
UR  - http://eteze.bg.ac.rs/application/showtheses?thesesId=7680
UR  - https://fedorabg.bg.ac.rs/fedora/get/o:22869/bdef:Content/download
UR  - http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=2048438370
UR  - https://nardus.mpn.gov.rs/handle/123456789/17590
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3723
AB  - Ligandi imidazolinskih receptora predstavljaju veliku grupu biološki aktivnih jedinjenja koja svoju aktivnost ostvaruju delovanjem na imidazolinske receptore (I1-IR, I2-IR, and I3-IR) i na α2-adrenergičke receptore (α2-AR). Centralni antihipertenzivni efekat imidazolina kao što su klonidin, rilmenidin i moksonidin je rezultat aktivacije I1-IR and α2-AR. I2-imidazolinski receptori predstavljaju katalitičko mesto monoamino oksidaze B (MAO-B), enzima koji je uključen u nekolio neuroloških poremećaja. Jedinjenja kao što su idazoksan i njegovi analozi pokazuju visok afinitet za ovaj tip receptora. I3-IRs imaju ulogu u indukciju sekrecije insulina iz β-ćelija pankreasa i održavanje homeostaze glukoze. Imajući u vidu da većina liganada imidazolinskih receptora svoje efekate ostvaruje unutar centralnog nervnog sistema (CNS) delujući kao centralni antihipertenzivi i/ili su potencijalni lekovi u lečenju neuroloških oboljenja, procena njihove permeabilnosti kroz krvno-moždanu barijeru (KMB) je od suštinskog značaja u ranom otkriću lekova.U ovoj disertaciji KMB permeabilnost 18 liganda α2-adrenergičkih i/ili imidazolinskih receptora i 22 leka koja deluju na CNS je ispitana primenom paralelnog testa permeabilnosti na veštačkim membrana (eng. Parallel Artificial Membrane Permeability Assay, PAMPA) i bioparticione micelarne hromatografije (eng. Biopartitioning Micellar Chromatography, BMC). Vrednosti dobijene PAMPA (logPe) i BMC (logkBMC) su dalje analizirane kvantitativnim odnosom strukture i permeabilnosti jedinjenja (eng. Quantitative Structure-Permeability Relationship, QSPR).Dominantni molekulski/kajonski oblici na pH = 7,4 su određeni korišćenjem MarvinSketch 6.1.0 softvera. Geometrija odabranih molekulskih/katjonskih oblika ispitivanih jedinjenja je optimizovana primenom B3LYP /6-31G (d,p) nivoa Density Functional Theory (DTF) u ChemBio3D Ultra 13.0 programu. Deskriptori optimizovanih struktura su izračunati u ChemBio3D Ultra 13.0, Dragon 6.0 i ADMET Predictor 6.5 programima. logPe i logkBMC vrednosti su korišćene kao zavisne varijable (Y), dok suizračunati molekulski parametri predstavljali nezavisne varijable (X) u QSPR studiji.
AB  - Imidazoline receptor ligands are a numerous family of biologically active compounds known to produce central hypotensive effect by interaction with both α2-adrenoreceptors (α2-AR) and imidazoline receptors (I1-IR, I2-IR, and I3-IR). The central hypotensive effect of imidazoline derivatives such as clonidine, rilmenidine and moxonidine is results of activation both I1-IR and α2-AR. I2-IRs have been shown to be modulatory site for monoamine oxidase-B, enzyme responsible for several neurological disorders. This type of imidazoline ligand receptors have high affinity for idazoxan and its analogues. I3-IRs are involved in induction of insulin secretion from β-cells and maintaining glucose homeostasis. Since the most IRs ligands are examined as centrally acting antihypertensives and/or drug candidates for treatment of various neurological diseases, predicting their brain penetration is a critical step in early drug discovery phase.In the framework of this doctoral dissertation, the effective Blood–Brain Barrier (BBB) permeability of 18 IRs/ α2-AR ligands and 22 Central Nervous System (CNS) drugs was experimentally determined by using both Parallel Artificial Membrane Permeability Assay (PAMPA) and Biopartitioning Micellar Chromatography (BMC) and further studied by the Quantitative-Structure-Permeability Relationship (QSPR) methodology.The dominant molecules/cations species of compounds have been calculated at pH = 7.4 by using MarvinSketch 6.1.0 software. The analyzed ligands were optimized using Density Functional Theory (B3LYP/6-31G(d,p)) included in ChemBio3D Ultra 13.0 program and molecule descriptors for optimized compounds were calculated using ChemBio3D Ultra 13.0, Dragon 6.0 and ADMET predictor 6.5 software. PAMPA effective permeabilities of examined compounds (logPe) and their logkBMC values were used as dependent variable (Y), while calculated molecular parametres were used as independent variables (X) in the QSPR study. SIMCA P+ 12.0 was used for Partial Least Square (PLS) analysis, while the stepwise Multiple Linear Regression (MLR) and Artificial Neural Networks (ANN) modeling were performed using STASTICA Neural Networks 4.0. Predictive potential of the formed models was confirmed by Leave-One-Out Cross- and external-validation and the most reliable models were selected.The descriptors that are important for model building are identified as well as their influence on BBB permeability...
PB  - Универзитет у Београду, Фармацеутски факултет
T2  - Универзитет у Београду
T1  - Heminformatička analiza, dizajn i ispitivanje proapoptotske aktivnosti novih liganada imidazolinskih receptora
UR  - https://hdl.handle.net/21.15107/rcub_nardus_17590
ER  - 
@phdthesis{
author = "Vučićević, Jelica",
year = "2020",
abstract = "Ligandi imidazolinskih receptora predstavljaju veliku grupu biološki aktivnih jedinjenja koja svoju aktivnost ostvaruju delovanjem na imidazolinske receptore (I1-IR, I2-IR, and I3-IR) i na α2-adrenergičke receptore (α2-AR). Centralni antihipertenzivni efekat imidazolina kao što su klonidin, rilmenidin i moksonidin je rezultat aktivacije I1-IR and α2-AR. I2-imidazolinski receptori predstavljaju katalitičko mesto monoamino oksidaze B (MAO-B), enzima koji je uključen u nekolio neuroloških poremećaja. Jedinjenja kao što su idazoksan i njegovi analozi pokazuju visok afinitet za ovaj tip receptora. I3-IRs imaju ulogu u indukciju sekrecije insulina iz β-ćelija pankreasa i održavanje homeostaze glukoze. Imajući u vidu da većina liganada imidazolinskih receptora svoje efekate ostvaruje unutar centralnog nervnog sistema (CNS) delujući kao centralni antihipertenzivi i/ili su potencijalni lekovi u lečenju neuroloških oboljenja, procena njihove permeabilnosti kroz krvno-moždanu barijeru (KMB) je od suštinskog značaja u ranom otkriću lekova.U ovoj disertaciji KMB permeabilnost 18 liganda α2-adrenergičkih i/ili imidazolinskih receptora i 22 leka koja deluju na CNS je ispitana primenom paralelnog testa permeabilnosti na veštačkim membrana (eng. Parallel Artificial Membrane Permeability Assay, PAMPA) i bioparticione micelarne hromatografije (eng. Biopartitioning Micellar Chromatography, BMC). Vrednosti dobijene PAMPA (logPe) i BMC (logkBMC) su dalje analizirane kvantitativnim odnosom strukture i permeabilnosti jedinjenja (eng. Quantitative Structure-Permeability Relationship, QSPR).Dominantni molekulski/kajonski oblici na pH = 7,4 su određeni korišćenjem MarvinSketch 6.1.0 softvera. Geometrija odabranih molekulskih/katjonskih oblika ispitivanih jedinjenja je optimizovana primenom B3LYP /6-31G (d,p) nivoa Density Functional Theory (DTF) u ChemBio3D Ultra 13.0 programu. Deskriptori optimizovanih struktura su izračunati u ChemBio3D Ultra 13.0, Dragon 6.0 i ADMET Predictor 6.5 programima. logPe i logkBMC vrednosti su korišćene kao zavisne varijable (Y), dok suizračunati molekulski parametri predstavljali nezavisne varijable (X) u QSPR studiji., Imidazoline receptor ligands are a numerous family of biologically active compounds known to produce central hypotensive effect by interaction with both α2-adrenoreceptors (α2-AR) and imidazoline receptors (I1-IR, I2-IR, and I3-IR). The central hypotensive effect of imidazoline derivatives such as clonidine, rilmenidine and moxonidine is results of activation both I1-IR and α2-AR. I2-IRs have been shown to be modulatory site for monoamine oxidase-B, enzyme responsible for several neurological disorders. This type of imidazoline ligand receptors have high affinity for idazoxan and its analogues. I3-IRs are involved in induction of insulin secretion from β-cells and maintaining glucose homeostasis. Since the most IRs ligands are examined as centrally acting antihypertensives and/or drug candidates for treatment of various neurological diseases, predicting their brain penetration is a critical step in early drug discovery phase.In the framework of this doctoral dissertation, the effective Blood–Brain Barrier (BBB) permeability of 18 IRs/ α2-AR ligands and 22 Central Nervous System (CNS) drugs was experimentally determined by using both Parallel Artificial Membrane Permeability Assay (PAMPA) and Biopartitioning Micellar Chromatography (BMC) and further studied by the Quantitative-Structure-Permeability Relationship (QSPR) methodology.The dominant molecules/cations species of compounds have been calculated at pH = 7.4 by using MarvinSketch 6.1.0 software. The analyzed ligands were optimized using Density Functional Theory (B3LYP/6-31G(d,p)) included in ChemBio3D Ultra 13.0 program and molecule descriptors for optimized compounds were calculated using ChemBio3D Ultra 13.0, Dragon 6.0 and ADMET predictor 6.5 software. PAMPA effective permeabilities of examined compounds (logPe) and their logkBMC values were used as dependent variable (Y), while calculated molecular parametres were used as independent variables (X) in the QSPR study. SIMCA P+ 12.0 was used for Partial Least Square (PLS) analysis, while the stepwise Multiple Linear Regression (MLR) and Artificial Neural Networks (ANN) modeling were performed using STASTICA Neural Networks 4.0. Predictive potential of the formed models was confirmed by Leave-One-Out Cross- and external-validation and the most reliable models were selected.The descriptors that are important for model building are identified as well as their influence on BBB permeability...",
publisher = "Универзитет у Београду, Фармацеутски факултет",
journal = "Универзитет у Београду",
title = "Heminformatička analiza, dizajn i ispitivanje proapoptotske aktivnosti novih liganada imidazolinskih receptora",
url = "https://hdl.handle.net/21.15107/rcub_nardus_17590"
}
Vučićević, J.. (2020). Heminformatička analiza, dizajn i ispitivanje proapoptotske aktivnosti novih liganada imidazolinskih receptora. in Универзитет у Београду
Универзитет у Београду, Фармацеутски факултет..
https://hdl.handle.net/21.15107/rcub_nardus_17590
Vučićević J. Heminformatička analiza, dizajn i ispitivanje proapoptotske aktivnosti novih liganada imidazolinskih receptora. in Универзитет у Београду. 2020;.
https://hdl.handle.net/21.15107/rcub_nardus_17590 .
Vučićević, Jelica, "Heminformatička analiza, dizajn i ispitivanje proapoptotske aktivnosti novih liganada imidazolinskih receptora" in Универзитет у Београду (2020),
https://hdl.handle.net/21.15107/rcub_nardus_17590 .

DSpace software copyright © 2002-2015  DuraSpace
О ФарФаР-у | Пошаљите запажања

OpenAIRERCUB
 

 

Комплетан репозиторијумГрупеАуториНасловиТемеОва институцијаАуториНасловиТеме

Статистика

Преглед статистика

DSpace software copyright © 2002-2015  DuraSpace
О ФарФаР-у | Пошаљите запажања

OpenAIRERCUB